Variant report
Variant | nsv466279 |
---|---|
Chromosome Location | chr9:17699981-17726581 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs717372 | chr9:17699981-17699982 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs35908750 | chr9:17699994-17699995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs74516771 | chr9:17700028-17700029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11791082 | chr9:17700029-17700030 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs552646868 | chr9:17700041-17700042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73645144 | chr9:17700056-17700057 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs201724373 | chr9:17700060-17700061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535254503 | chr9:17700068-17700069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190316390 | chr9:17700125-17700126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575417843 | chr9:17700135-17700136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141535434 | chr9:17700139-17700140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558637781 | chr9:17700152-17700153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577417180 | chr9:17700182-17700183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541581687 | chr9:17700188-17700189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147726149 | chr9:17700195-17700196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568251730 | chr9:17700200-17700201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559872927 | chr9:17700227-17700228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78295587 | chr9:17700236-17700237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542032464 | chr9:17700268-17700269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73645145 | chr9:17700293-17700294 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs182554505 | chr9:17700334-17700335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150883346 | chr9:17700364-17700365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs998599 | chr9:17700366-17700367 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs6475164 | chr9:17700375-17700376 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs138285046 | chr9:17700389-17700390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567793190 | chr9:17700405-17700406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185936884 | chr9:17700407-17700408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142864251 | chr9:17700420-17700421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376991795 | chr9:17700495-17700496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs74305189 | chr9:17700560-17700561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114171387 | chr9:17700564-17700565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146046251 | chr9:17700573-17700574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74305190 | chr9:17700587-17700588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534996044 | chr9:17700632-17700633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1000770 | chr9:17700646-17700647 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs4461996 | chr9:17700650-17700651 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs189856330 | chr9:17700726-17700727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563684192 | chr9:17700728-17700729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575792393 | chr9:17700758-17700759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546221405 | chr9:17700776-17700777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564423376 | chr9:17700848-17700849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181115875 | chr9:17700860-17700861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11795147 | chr9:17700871-17700872 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs140048432 | chr9:17700893-17700894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112639080 | chr9:17700895-17700896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs149743728 | chr9:17700932-17700933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528937774 | chr9:17700944-17700945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576720648 | chr9:17701035-17701036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185762761 | chr9:17701043-17701044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190357032 | chr9:17701055-17701056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 22183965 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Thoracic aortic aneurysm | 21698135 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:17699400-17700600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:17699400-17700600 | Enhancers | Fetal Brain Male | brain |
3 | chr9:17699800-17700600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr9:17699800-17701400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr9:17706800-17707400 | Enhancers | Fetal Intestine Large | intestine |
6 | chr9:17707200-17707600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr9:17707400-17707800 | Weak transcription | Fetal Intestine Large | intestine |
8 | chr9:17707600-17708400 | Flanking Active TSS | Pancreatic Islets | Pancreatic Islet |
9 | chr9:17707800-17708200 | Enhancers | Fetal Intestine Large | intestine |
10 | chr9:17708400-17709600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr9:17720800-17721200 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr9:17721000-17721200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr9:17721800-17722400 | Enhancers | Dnd41 | blood |
14 | chr9:17722800-17723200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr9:17725600-17726400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr9:17725800-17726800 | Enhancers | Liver | Liver |